As a key transcription factor, SIX1 has been implicated in the glucose metabolism that promotes glycolysis and tumor growth by stimulating glycolytic genes (such as GLUT1, ENO1, and LDHA) transcription (Li et al. 2018). Here, ENO1 is linked to neoplasm.